Pharmaceuticals, Biotechnology and Life Sciences
DALLAS–(BUSINESS WIRE)–Peloton Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing first-in-class oral medicines for cancer and other serious conditions, announced that…
AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research, an integrated research organization (IRO), announced today $20 million in Series C funding led by…
– Announces USAN selection of omidubicel as nonproprietary name for company’s investigational NAM-expanded hematopoietic stem cells (formerly known as NiCord®)…
Q3’19 revenue of $617.5 million decreased 2% as-reported, but increased 2% in constant currency, from Q3’18, while Q3’19 YTD revenue…
Patients across all age subgroups treated with ozanimod lost less cortical grey matter volume than did those treated with interferon…
Kraig Labs signs factory lease to expand production capacity ANN ARBOR, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KBLB&src=ctag" target="_blank"gt;$KBLBlt;/agt; lt;a href="https://twitter.com/hashtag/KBLB?src=hash" target="_blank"gt;#KBLBlt;/agt;–Kraig Biocraft Laboratories,…
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that Gaurav Shah,…
– Process Could Significantly Reduce Cannabinoid Production Time – TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA:…
Open-label, long-term extension data show durability of zilucoplan treatment effect, with sustained improvements observed in primary and secondary endpoints at…
SYRACUSE, N.Y.–(BUSINESS WIRE)–Repair Biotechnologies, Inc. announced today $2.15 million in seed venture funding, to accelerate the preclinical development of its…